Dr David Lee Dai Wee is a consultant clinical oncologist at the University of Malaya Medical Centre and lecturer at the Faculty of Medicine, University of Malaya. He received his undergraduate medical education at International Medical University (IMU), Malaysia, and subsequently Master of Clinical Oncology at the University of Malaya in 2020. Dr Lee also holds FRCR (Clinical Oncology) since 2022.

He completed a fellowship in experimental therapeutics under guidance of Dr Daniel Tan at the National Cancer Centre Singapore, involving in the conduct of more than 40 early phase clinical trials. His area of interest is in early-phase clinical trials, thoracic oncology, and head and neck oncology. 

Dr Lee is the inaugural recipient of the American Society of Clinical Oncology (ASCO) Leadership Development Program - Asia Pacific award in 2021-2022. Currently Dr Lee is a member of the ASCO Trainee and Early Career Advisory Group, ASCO Membership Advisory Group and IASLC Multidisciplinary Clinical Science Committee.